Small interfering RNA (siRNA) has become the cornerstone
against
undruggable targets and for managing metastatic breast cancer. However,
an effective gene silencing approach is faced with a major challenge
due to the delivery problem. In our present study, we have demonstrated
efficient siRNA delivery, superior gene silencing, and inhibition
of metastasis in triple-negative breast cancer cells (MDA-MB-231)
using rod-shaped (aspect ratio: 4) multivalent peptide-functionalized
gold nanoparticles and compared them to monovalent free peptide doses.
Multivalency is a new concept in biology, and tuning the physical
parameters of multivalent nanoparticles can enhance gene silencing
and antitumor efficacy. We explored the effect of the multivalency
of shape- and size-dependent peptide-functionalized gold nanoparticles
in siRNA delivery. Our study demonstrates that peptide functionalization
leads to reduced toxicity of the nanoparticles. Such designed peptide-functionalized
nanorods also demonstrate antimetastatic efficacy in Notch1-silenced
cells by preventing EMT progression in vitro. We
have shown siRNA delivery in the hard-to-transfect primary cell line
HUVEC and also demonstrated that the Notch1-silenced MDA-MB-231 cell
line has failed to form nanobridge-mediated foci with the HUVEC in
the co-culture of HUVEC and MDA-MB-231, which promote metastasis.
This antimetastatic effect is further checked in a xenotransplant in vivo zebrafish model. In vivo studies
also suggest that our designed nanoparticles mediated inhibition of
micrometastasis due to silencing of the Notch1 gene. The outcome of
our study highlights that the structure–activity relationship
of multifunctional nanoparticles can be harnessed to modulate their
biological activity.